MEDICOVER ABMEDICOVER ABMEDICOVER AB

MEDICOVER AB

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.06EUR
Revenue estimate
‪503.25 M‬EUR
Market capitalization
‪2.23 B‬EUR
‪18.06 M‬EUR
‪1.79 B‬EUR
‪64.36 M‬
Beta (1Y)
0.73

About MEDICOVER AB SER. B

CEO
Fredrik Rågmark
Headquarters
Stockholm
Employees (FY)
‪45.32 K‬
Founded
2016
ISIN
SE0009778848
FIGI
BBG00GSNV8Q3
Medicover AB engages in the provision of invitro diagnostics and healthcare services. It operates through the Healthcare Services and Diagnostic Services segments. The Healthcare Services segment includes the provision of employer funded healthcare services for employees and sometimes their families. The Diagnostic Services segment offers a broad range of routine and advanced laboratory testing across all clinical pathology areas. The company was founded in 1995 and is headquartered in Stockholm, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDICOVER AB stocks are traded under the ticker 5M0B.
MEDICOVER AB is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
5M0B earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.03 EUR resulting in a 178.57% surprise. The estimated earnings for the next quarter are 0.03 EUR per share. See more details about MEDICOVER AB earnings.
MEDICOVER AB revenue for the last quarter amounts to ‪461.90 M‬ EUR despite the estimated figure of ‪466.95 M‬ EUR. In the next quarter revenue is expected to reach ‪496.47 M‬ EUR.
Yes, you can track MEDICOVER AB financials in yearly and quarterly reports right on TradingView.
5M0B net income for the last quarter is ‪6.06 M‬ EUR, while the quarter before that showed ‪11.90 M‬ EUR of net income which accounts for −49.12% change. Track more MEDICOVER AB financial stats to get the full picture.
Yes, 5M0B dividends are paid annually. The last dividend per share was 0.12 EUR. As of today, Dividend Yield (TTM)% is 0.80%. Tracking MEDICOVER AB dividends might help you take more informed decisions.
MEDICOVER AB dividend yield was 0.94% in 2023, and payout ratio reached 103.89%. The year before the numbers were 0.97% and 161.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 5M0B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICOVER AB stock right from TradingView charts — choose your broker and connect to your account.
5M0B reached its all-time high on Jan 3, 2022 with the price of 35.96 EUR, and its all-time low was 0.24 EUR and was reached on Jan 13, 2009.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪45.32 K‬ employees. See our rating of the largest employees — is MEDICOVER AB on this list?
We've gathered analysts' opinions on MEDICOVER AB future price: according to them, 5M0B price has a max estimate of 18.82 EUR and a min estimate of 15.40 EUR. Read a more detailed MEDICOVER AB forecast: see what analysts think of MEDICOVER AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDICOVER AB EBITDA is ‪255.84 M‬ EUR, and current EBITDA margin is 13.70%. See more stats in MEDICOVER AB financial statements.